Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders |
CAMDEN NATIONAL CORP (CAC)
|
Add to portfolio |
|
|
Price: |
$49.27
| | Metrics |
OS: |
14.6
|
M
| |
12
|
% ROE
|
Market cap: |
$717
|
M
| |
9
|
% ROIC
|
|
|
| |
|
|
|
|
| | | |
| | | | | |
TTM Valuation | | | |
|
|
| |
|
|
|
|
| |
|
|
EPS |
$3.74
| |
13.2
|
x P/E
|
BVPS
|
$32.11
| |
1.53
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 183.9 | 190.4 | 174.4 | 166.9 | 157.7 | 150.9 | 147.4 | 112.0 |
Revenue growth | -3.4% | 9.2% | 4.5% | 5.8% | 4.5% | 2.3% | 31.6% | 13.8% |
Cost of goods sold | 69.6 | 68.5 | 65.5 | 61.5 | 58.4 | 56.0 | 54.3 | 42.9 |
Gross profit | 114.3 | 121.8 | 108.9 | 105.3 | 99.3 | 94.9 | 93.1 | 69.1 |
Gross margin | 62.2% | 64.0% | 62.4% | 63.1% | 63.0% | 62.9% | 63.1% | 61.7% |
Selling, general and administrative | | | | | | | | |
General and administrative | 4.1 | 3.7 | 3.8 | 3.7 | 3.8 | 3.1 | 3.2 | 2.6 |
EBITA | 110.2 | 118.1 | 105.0 | 101.6 | 95.6 | 91.8 | 89.9 | 62.0 |
EBITA margin | 59.9% | 62.1% | 60.2% | 60.9% | 60.6% | 60.8% | 60.9% | 55.3% |
Amortization of intangibles | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 1.8 | 1.9 | 1.3 |
EBIT | 109.6 | 117.5 | 104.3 | 100.9 | 94.9 | 89.9 | 88.0 | 60.7 |
EBIT margin | 59.6% | 61.7% | 59.8% | 60.5% | 60.1% | 59.6% | 59.7% | 54.2% |
Pre-tax income | 77.0 | 86.6 | 74.4 | 71.6 | 65.8 | 62.4 | 57.5 | 30.9 |
Income taxes | 15.6 | 17.6 | 14.9 | 14.4 | 12.7 | 33.9 | 17.5 | 9.9 |
Tax rate | 20.3% | 20.3% | 20.0% | 20.1% | 19.3% | 54.3% | 30.4% | 32.1% |
Net income | 61.4 | 69.0 | 59.5 | 57.2 | 53.1 | 28.5 | 40.1 | 21.0 |
Net margin | 33.4% | 36.3% | 34.1% | 34.3% | 33.6% | 18.9% | 27.2% | 18.7% |
|
Diluted EPS | $4.18 | $4.61 | $3.96 | $3.70 | $3.40 | $1.83 | $2.58 | $1.74 |
Shares outstanding (diluted) | 14.7 | 15.0 | 15.0 | 15.5 | 15.6 | 15.6 | 15.5 | 12.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|